Cargando…
Prevalence of the most frequent BRCA1 mutations in Polish population
The purpose of our study was to establish the frequency and distribution of the four most common BRCA1 mutations in Polish general population and in a series of breast cancer patients. Analysis of the population frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG) a...
Autores principales: | Brozek, Izabela, Cybulska, Celina, Ratajska, Magdalena, Piatkowska, Magdalena, Kluska, Anna, Balabas, Aneta, Dabrowska, Michalina, Nowakowska, Dorota, Niwinska, Anna, Pamula-Pilat, Jolanta, Tecza, Karolina, Pekala, Wioletta, Rembowska, Jolanta, Nowicka, Karina, Mosor, Maria, Januszkiewicz-Lewandowska, Danuta, Rachtan, Jadwiga, Grzybowska, Ewa, Nowak, Jerzy, Steffen, Jan, Limon, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132391/ https://www.ncbi.nlm.nih.gov/pubmed/21503673 http://dx.doi.org/10.1007/s13353-011-0040-6 |
Ejemplares similares
-
Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases
por: Brozek, Izabela, et al.
Publicado: (2012) -
Genetic 3′UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients
por: Pamuła-Piłat, Jolanta, et al.
Publicado: (2020) -
High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk
por: Wagner, Kerstin, et al.
Publicado: (2007) -
Copper transport system and response to ovarian cancer chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015) -
Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2015)